An 18-Year Dataset on the Clinical Incidence and MICs to Antibiotics of <i>Achromobacter</i> spp. (Labeled Biochemically or by MAL-DI-TOF MS as <i>A. xylosoxidans</i>), Largely in Patient Groups Other than Those with CF
<i>Achromobacter</i> spp. are intrinsically multidrug-resistant environmental microorganisms which are known to cause opportunistic, nosocomial, and sometimes chronic infections. The existing literature yields scarcely any larger datasets, especially with regard to the incidence in patie...
Saved in:
Main Authors: | Claudio Neidhöfer (Author), Christina Berens (Author), Marijo Parčina (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections
by: Shani Zilberman-Itskovich, et al.
Published: (2024) -
ESKAPEE Pathogen Biofilm Control on Surfaces with Probiotic <i>Lactobacillaceae</i> and <i>Bacillus</i> species
by: Claudio Neidhöfer, et al.
Published: (2023) -
Successful Treatment of Aortic Endocarditis by <i>Achromobacter xylosoxidans</i> with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review
by: Gianfranco La Bella, et al.
Published: (2022) -
Achromobacter xylosoxidans Causing Late-onset Sepsis with Pneumonia in a Term Neonate
by: BASANY LAXMAN, et al.
Published: (2022) -
Native-valve endocarditis caused by Achromobacter xylosoxidans: a case report and review of literature
by: Caio Godoy Rodrigues, et al.
Published: (2017)